Novartis Ceritinib India Case: Court Rebuke Amid Wait For Patent Decision

An Indian court has frowned upon Novartis and opponent Natco for seemingly delaying proceedings before the Controller General of Patents in a case concerning the Swiss firm’s anticancer ceritinib. The patent office wasn’t spared either, with the court asking the Controller to ensure that once orders are reserved, a time period is prescribed for delivering the decision.